Pharmaceutical composition, processes for treating viral infections by administering a pharmaceutically safe and effective amount of a pharmaceutical composition, use of lamivudine or a pharmaceutically acceptable derivative thereof, and process for the preparation of a pharmaceutical composition.

摘要

"PHARMACEUTICAL COMPOSITION, PROCESSES FOR TREATMENT OF VIRAL INFECTIONS BY THE ADMINISTRATION OF A PHARMACEUTICALLY SAFE AND EFFECTIVE QUANTITY OF A PHARMACEUTICAL COMPOSITION, USE OF LAMIVUDINE OR ITS PHARMACEUTICALLY ACCEPTABLE, PHARMACEUTICAL AND ACCESSIBLE DERIVATIVE. The present invention relates to new pharmaceutical formulations containing (2R, cis) -4-amino-1- (2-hydroxymethyl-1,3-oxathiolan-5-yl) - (1H) -pyrimidin-2-one (( -) - 2 ', 3'-dideoxy, 3'-thiacitidine, Epivir 32, lamivudine) and its use in medical therapy.